The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Liver Disease Diagnostics Market Expected To Change Between 2026 And 2030?
The liver disease diagnostics market size has demonstrated robust growth in recent years. It is anticipated to increase from $38.95 billion in 2025 to $41.84 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This historical growth can be attributed to the increasing prevalence of hepatitis infections, rising alcohol consumption patterns, an early reliance on blood-based liver tests, the growing incidence of liver cirrhosis, and the expansion of hospital diagnostic infrastructure.
The liver disease diagnostics market is anticipated to experience substantial expansion over the coming years. This market is projected to reach $55.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This projected growth is driven by factors such as the increasing prevalence of NAFLD and NASH, heightened understanding of proactive liver care, wider implementation of sophisticated imaging methods, an increase in population health screening initiatives, and greater investment in diagnostic healthcare services. Key trends anticipated during this period encompass an escalating need for prompt liver disease identification, a surge in the application of non-invasive diagnostic approaches, more extensive screening for fatty liver and fibrosis, broadened routine liver function assessments, and an increased clinical emphasis on tracking disease progression.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp
Which Economic Or Industry Drivers Are Impacting The Liver Disease Diagnostics Market?
A rise in alcohol consumption is anticipated to stimulate the expansion of the liver disease diagnostics market moving forward. The intake of alcohol is growing, attributed to factors such as shifting social customs, greater affordability, widespread accessibility, and an increase in stress or mental health issues. Liver disease diagnostics are essential for observing the impact of alcohol consumption on liver well-being, aiding in the detection of initial indicators of liver damage like fatty liver, hepatitis, or cirrhosis. As an illustration, in December 2024, according to the Bureau of Labor Statistics, a US-based government agency, in 2023, U.S. households spent an average of $294 on alcoholic beverages consumed at home and $343 on those consumed outside the home. Consequently, the increasing alcohol consumption is fueling the growth of the liver disease diagnostics market.
How Is The Liver Disease Diagnostics Market Structured Across Different Segments?
The liver disease diagnostics market covered in this report is segmented –
1) By Diagnosis Technique: Laboratory Tests, Imaging, Biopsy, Other Diagnosis Techniques
2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases
3) By End Users: Hospitals, Laboratories, Other End Users
Subsegments:
1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Serological Tests
2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)
3) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy
4) By Other Diagnosis Techniques: Biomarker Testing, Fibrosis Scoring Systems
Which Trends Are Impacting The Growth Of The Liver Disease Diagnostics Market?
Leading companies operating in the liver disease diagnostics market are concentrating on developing innovative solutions, such as non-invasive tools for liver assessment, to establish more accurate and efficient diagnostic methods. A non-invasive tool for liver assessment refers to diagnostic methods that evaluate liver conditions using techniques like elastography or blood tests, thereby avoiding the necessity for invasive procedures such as biopsies. For instance, in September 2024, City Imaging & Clinical, an India-based diagnostic center, introduced FibroScan, a non-invasive diagnostic tool for liver assessment, aimed at the early detection of liver diseases including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This advanced technology enables rapid and accurate measurements of liver stiffness and fat content without requiring invasive procedures like biopsies. The procedure is quick, typically lasting 5 to 15 minutes, and involves positioning a probe on the skin over the liver. The probe emits sound waves, which gauge liver tissue stiffness, assisting in the assessment of fibrosis or scarring.
Which Major Players Dominate The Liver Disease Diagnostics Market?
Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, bioMérieux SA, Echosens SA, Hologic Inc., Canon Medical Systems Corporation, GE HealthCare Technologies Inc., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Bruker Corporation, Sysmex Corporation, DiaSorin S.p.A., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., HEPQuant LLC, Aiforia Technologies Plc
Read the full liver disease diagnostics market report here:
https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report
What Are The Top-Performing Regions Within The Liver Disease Diagnostics Market?
North America was the largest region in the liver disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Liver Disease Diagnostics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp
Browse Through More Reports Similar to the Global Liver Disease Diagnostics Market 2026, By The Business Research Company
Hepatitis Diagnostic Tests Global Market Report
https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report
Liver Diseases Therapeutics Global Market Report
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report
Clinical Diagnostics Global Market Report
https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model